Indeed, in ERα-positive breast cancer cells, it has been demonstrated that among the mechanisms through which low adiponectin levels stimulate cell proliferation, there is the upregulation of Cyclin D1 and the inhibition of LKB1/AMPK/mTOR signaling [57,83]. Here, ADIPOQ is linked to breast carcinoma.